Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by digoxin III, a new digoxin immunoassay

Therapeutic Drug Monitoring

Volumn 30, Issue 1, 2008, Pages 95-99

  Reyes, Meredith A ^a   Actor, Jeffrey K ^a   Risin, Semyon A ^a   Dasgupta, Amitava ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Chan Su; Digoxin III; Interference; Lu Shen Wan

Indexed keywords

CHAN SU; CHINESE DRUG; DIGOXIN; LU SHEN WAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CROSS REACTION; DIGOXIN BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG MONITORING; DRUG POTENTIATION; DRUG STRUCTURE; FEMALE; IMMUNOASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BUFANOLIDES; CROSS REACTIONS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FLUORESCENCE POLARIZATION; HERB-DRUG INTERACTIONS; HUMANS; IMMUNOASSAY; MICE; SENSITIVITY AND SPECIFICITY;

EID: 38549168063     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31816457c7     Document Type: Article

References (20)

1. Tindal HA, Davis RB, Phillips RS, et al. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005;11:42-49.
2. Johnson SK, Blanchard A. Alternative medicine and herbal use among university students. J Am Coll Health. 2006;55:163-168.
3. Hong Z, Chan K, Yeung HW. Simultaneous determination of bufadienolides in traditional Chinese medicine preparations, Liu-Shen-Wan by liquid chromatography. J Pharm Pharmacol. 1992;44:1023-1026.
4. Chan WY, Ng TB, Yeung HW. Examination for toxicity of a Chinese drug, the total glandular secretion product Chan Su in pregnant mice and embryos. Biol Neonate. 1995;67:376-380.
5. Chen KK, Kovarikove A. Pharmacology and toxicology of toad venom. J Pharm Sci. 1967;56:1535-1541.
6. Morishita S, Shoji M, Oguni Y, et al. Pharmacological actions of 'Kyushin' a drug containing toad venom: cardiotonic and arrhythmogenic effects and excitatory effect on respiration. Am J Chin Med. 1992;20:245-246.
7. Pamnani MB, Chen S, Bryant HJ, et al. Effect of three sodium-potassium adenosine triphosphate inhibitors. Hypertension. 1991;18:316-324.
8. Ko R, Greenwald M, Loscutoff S, et al. Lethal ingestion of Chinese tea containing Chan Su. West J Med. 1996;164:71-75.
9. Fushimi R, Koh T, Iyama S, et al. Digoxin like immunoreactivity in Chinese medicine. Ther Drug Monit. 1990;12:242-245.
10. Panesar NS. Bufalin and unidentified substances in traditional Chinese medicine cross react in commercial digoxin assay. Clin Chem. 1992;38:2155-2156.
11. Panesar NS, Chan KW, Law LK. Changing characteristics of TDx digoxin II assay in detecting bufadienolides in a traditional Chinese medicine: for better or worse. Ther Drug Monit. 2005;27:677-679.
12. Dasgupta A, Biddle D,Wells A, et al. Positive and negative interference of Chinese medicine Chan Su in serum digoxin measurement: elimination of interference using a monoclonal chemiluminescent immunoassay or monitoring free digoxin concentrations. Am J Clin Pathol. 2000;114:174-179.
13. Ward SB, Sjostorm L, Ujhelyi MR. Comparison of pharmacokinetics and in vivo bioaffinity of DigiTAb versus Digibind. Ther Drug Monit. 2000;22:599-607.
14. McMillin GA, Qwen W, Lambert TL, et al. Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays. Clin Chem. 2002;48:1580-1584.
15. Dasgupta A. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances. Toxicol Rev. 2006;25:273-281.
16. SteimerW, Muller C, Eber B, et al. Intoxication due to negative canrenone interference in digoxin drug monitoring [Letter]. Lancet. 1999;354:1176-1177.
17. Steimer W, Muller C, Eber B. Digoxin assays: frequent, substantial and potentially dangerous interference by spironolactone, canrenone and other steroids. Clin Chem. 2002;48:507-516.
18. Cao Y, Zhao L, Liang Q, et al. Study of determination and pharmacokinetics of bufadienolides in dog's plasma after administration of Liu-Shen-wan by high performance liquid chromatography time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;853:227-233.
19. Rainey P. Digibind and free digoxin [Letter]. Clin Chem. 1999;45:719-720.
20. Jortani SA, Pinar A, Johnson NA, et al. Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind). Clin Chim Acta. 1999;283:159-169.